Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

MedMen Enterprises Inc. MMNFF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
19/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

MedMen Enterprises Inc. (MMNFF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 18/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $141M, +3.4%/yr average growth. Net income is $166M (loss), growing at -5.4%/yr. Net profit margin is -117.6% (negative). Gross margin is 49.5% (+2.7 pp trend).

Balance sheet: total debt is $396M against $152M equity (Debt-to-Equity (D/E) ratio 2.61, leveraged). Current ratio is 0.49 (tight liquidity). Debt-to-assets is 122.5%. Total assets: $323M.

Analyst outlook: 0 / 1 analysts rate MMNFF as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 30/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 51/100 (Partial), Future 20/100 (Fail), Income 10/100 (Fail).

MMNFF SharesGrow Score Overview

28/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 30/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 51/100
Gross margin is + market cap
FUTURE 20/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MMNFF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
30/100
MMNFF: +3.4%/yr revenue is, -5.4%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
~
MOAT Partial
51/100
MMNFF: Gross margin is 49.5% (+2.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 51/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
20/100
Analyst outlook: 0 / 1 analysts rate MMNFF as buy (0%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
MMNFF: Net profit margin is -117.6%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range1.0E-4-0.036
Volume9.25K
Avg Volume (30D)1.03M
Market Cap$138.32K
Beta (1Y)1.40
Share Statistics
EPS (TTM)-0.14
Shares Outstanding$1.15B
IPO Date2018-05-30
Employees428
CEOMelony Valleau CPA
Financial Highlights & Ratios
Revenue (TTM)$140.81M
Gross Profit$69.73M
EBITDA$-35.56M
Net Income$-165.55M
Operating Income$-61.3M
Total Cash$13.53M
Total Debt$395.84M
Net Debt$385.04M
Total Assets$323.22M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Rating ConsensusHold
Analysts Covering1
Buy 0% Hold 100% Sell 0%
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINCA58507M1077

Price Chart

Track all markets on TradingView
MMNFF
MedMen Enterprises Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic

People Also View

CURLF
CURLF
Curaleaf Holdings, Inc.
$2.40
+0.04%
 GTBIF
GTBIF
Green Thumb Industries Inc.
$6.76
+0.30%
 TCNNF
TCNNF
Trulieve Cannabis Corp.
$6.47
+2.73%
 CRON
CRON
Cronos Group Inc.
$2.57
+0.78%
 TLRY
TLRY
Tilray Brands, Inc.
$6.91
+2.83%
 CCHWF
CCHWF
Columbia Care Inc.
$0.94
-21.71%
 CGC
CGC
Canopy Growth Corporation
$1.09
+0.93%
 VRNOF
VRNOF
Verano Holdings Corp.
$1.30
+8.33%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message